Targeted Therapies Forum Presented in English 2023 - Breakout Sessions 2

Video

This series includes videos from the breakout sessions presented by Dr. Stephen Liu, including the following topics:

  • Safety and Toxicity of Selpercatinib Versus Pralsetinib
  • The Future of RET+ NSCLC Treatment
  • NTRK+ NSCLC: Treatment Options and Side Effects
  • NRG1 Fusions: Treatment Options

To watch the complete playlist click here.

Targeted Therapies Forum Presented in English 2023 - Breakout Sessions

Video

This series includes videos from the breakout sessions presented by Dr. Stephen Liu and Dr. Misako Nagasaka, including the following topics:

  • Treatments and Study Data for Patients with ALK+ NSCLC
  • Treatment Options & Study Data for Patients with ROS1+ NSCLC
  • Rare Fusions in NSCLC: RET
  • RET Fusion Treatment: Selpercatinib
  • RET Fusion Treatment: Pralsetinib

To watch the complete playlist click here.

Subscribe to English